Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR.
Latest News
Share this


Moving to Lower Risk

A “silent” infarct is still an infarct whether random or iatrogenic. Until someone proves these DWI lesions are somehow beneficial to the patient, we need to take steps to prevent them from occurring. The fact of the matter is, no matter how “minor” or severe the...


Join Keystone Heart at EuroPCR 2018!

EuroPCR is coming up May 22-25 in Paris! The global event, hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), is one of our biggest events of the year. Over 12,000 participants come together to network, learn,and innovate. Over the course of the four days,...


REPRISE III Results Are In!

As a part of our medical community, we wanted to make sure you were aware of a recent article published by TCTMD. Full results of the REPRISE III trial comparing the mechanically expanded Boston Scientific’s Lotus transcatheter aortic valve replacement system to Medtronic’s self-expanding first-and second-generation...